Regulatory Solutions
-
End-To-End Safety Solutions Designed For Success
6/6/2023
As one of the world’s largest and most experienced safety and PV organizations, unearth how this provider is bringing extensive expertise and regulatory intelligence to every industry engagement.
-
Strategic Regulatory Documentation Practice
5/31/2023
Learn how this highly experienced and fully dedicated team is improving timeline creation complexities and management, resourcing, document interdependencies, and transmission to health authorities.
-
Only Elligo Mitigates Research Risk
4/18/2023
Uncertainty is inherent in clinical research. Uncover new strategies and solutions to alleviate risk so clinical teams can confidently and quickly bring products to market.
-
Scalable Manufacturing Of Sterile Drug Products
3/31/2023
Discover comprehensive clinical to commercial scale manufacturing services that deliver true life-cycle management for sterile drug products that bring treatments to patients with efficiency and quality.
-
TrialScope Intelligence Disclosure Regulatory Tracking
3/23/2023
TrialScope Intelligence provides global coverage, monitoring countries with and without current disclosure requirements and sending alerts for changes in regulations. English translations and expert analysis create additional context and further understanding of regulatory expectations.
-
See How You Can Start Your Early Phase Program 6-9 Weeks Earlier In Canada
3/23/2023
Vice President of Business Development Lisa Sanford explains whether you need an IND before starting your first-in-human trial in Canada.
-
IRB Services For Institutional Sites
3/2/2023
Advarra can serve as your partner for everything from single investigational sites to multisite research consortia and therapeutic networks.
-
Meeting Compliance Without Compromise
2/23/2023
Discover how services provided by the Institutional Review Board can assist institutions, academic research organizations, research consortia, and health systems.
-
CRO Of Choice For Cell And Gene Therapies
2/17/2023
Whatever a study’s unique considerations – patients, products, process, follow-up, regulatory – Veristat can successfully get you through it.
-
Navigating Early Phase CNS-Active Drug Development
2/14/2023
Early development of CNS-active drugs requires in-depth clinical expertise. Altasciences’ Dr. Beatrice Setnik, Chief Scientific Officer, examines the strategies to ensure early comprehensive data collection to fulfill regulatory requirements and aid in evaluating the risk/benefit profile.